CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Kala Pharmaceuticals, Inc.  (KALA)
Other Ticker:  
 

Kala Pharmaceuticals's Working Capital Ratio

KALA's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




KALA Working Capital Ratio (Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities Change 14.45 % - - - -
Y / Y Current Assets Change 53.65 % - - - -
Working Capital Ratio MRQ 10.7 6.39 10 21.71 7.97
Overall Ranking # # # # #
Seq. Current Liabilities Change 31.49 % 36.86 % 96.81 % -67.69 % -
Seq. Current Assets Change 120.03 % -12.49 % -9.35 % -11.98 % -



Working Capital Ratio forth quarter 2018 Comment
Kala Pharmaceuticals's Current Assets grew by 120.03 % in IV. Quarter sequntially, faster than Current Liabilities, this led to improvement in Kala Pharmaceuticals's Working Capital Ratio to 10.7, Working Capital Ratio remained below Kala Pharmaceuticals, Inc. average.

Within Major Pharmaceutical Preparations industry 52 other companies have achieved higher Working Capital Ratio than Kala Pharmaceuticals in forth quarter 2018. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is KALA most successful ?
Working Capital Ratio KALA on the trailing twelve month basis
Working Capital Ratio forth quarter 2018 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 53
Healthcare Sector # 94
Overall Market # 258


Working Capital Ratio Statistics
High Average Low
21.71 11.35 6.39
(Mar 31 2018)   (Sep 30 2018)




Financial Statements
Kala Pharmaceuticals's Current Liabilities $ 17 Millions Visit KALA's Balance sheet
Kala Pharmaceuticals's Current Assets $ 177 Millions Visit KALA's Balance sheet
Source of KALA's Sales Visit KALA's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingDec 31 2018, within Major Pharmaceutical Preparations Industry Working Capital RatioDec 31 2018 MRQ Current AssetsDec 31 2018 MRQ Current Liabilities
Prothena Corp Plc  28.90 $ 431.390  Millions$ 14.926  Millions
Medicinova Inc  28.63 $ 62.758  Millions$ 2.192  Millions
Arena Pharmaceuticals Inc  28.47 $ 460.725  Millions$ 16.181  Millions
Minerva Neurosciences, Inc.  24.94 $ 90.018  Millions$ 3.609  Millions
Glycomimetics Inc  24.23 $ 212.321  Millions$ 8.763  Millions
Achillion Pharmaceuticals Inc  23.28 $ 275.380  Millions$ 11.829  Millions
Xencor Inc  22.92 $ 315.727  Millions$ 13.774  Millions
Genprex, Inc.  22.81 $ 8.847  Millions$ 0.388  Millions
Ophthotech Corp.  22.71 $ 133.287  Millions$ 5.869  Millions
Marker Therapeutics, Inc.  22.11 $ 61.997  Millions$ 2.804  Millions
Crinetics Pharmaceuticals, Inc.  21.03 $ 166.683  Millions$ 7.925  Millions
Ra Pharmaceuticals, Inc.  20.82 $ 212.407  Millions$ 10.201  Millions
Concert Pharmaceuticals, Inc.  20.59 $ 180.149  Millions$ 8.749  Millions
Syros Pharmaceuticals, Inc.  19.40 $ 101.734  Millions$ 5.244  Millions
China Yct International Group, Inc.  19.27 $ 42.039  Millions$ 2.181  Millions
Restorbio, Inc.  19.16 $ 109.534  Millions$ 5.716  Millions
Kalvista Pharmaceuticals, Inc.  19.04 $ 124.063  Millions$ 6.515  Millions
Oragenics Inc  18.78 $ 21.933  Millions$ 1.168  Millions
Enanta Pharmaceuticals Inc  18.70 $ 423.310  Millions$ 22.632  Millions
Adial Pharmaceuticals, Inc.  18.19 $ 4.693  Millions$ 0.258  Millions
Evolus, Inc.  17.88 $ 94.339  Millions$ 5.276  Millions
Inspire Medical Systems, Inc.  17.86 $ 199.278  Millions$ 11.155  Millions
Nektar Therapeutics  17.53 $ 1,437.687  Millions$ 82.002  Millions
Paratek Pharmaceuticals, Inc.  17.10 $ 255.243  Millions$ 14.925  Millions
Aquinox Pharmaceuticals, Inc  16.68 $ 77.165  Millions$ 4.627  Millions
Dicerna Pharmaceuticals Inc  16.12 $ 405.514  Millions$ 25.162  Millions
Allogene Therapeutics, Inc.  15.89 $ 467.982  Millions$ 29.459  Millions
Savara Inc.  15.63 $ 113.344  Millions$ 7.254  Millions
Synlogic, Inc.  15.40 $ 124.338  Millions$ 8.073  Millions
Nucana Plc  15.02 $ 83.589  Millions$ 5.565  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CRGS's Profile

Stock Price

CRGS's Financials

Business Description

Fundamentals

Charts & Quotes

CRGS's News

Suppliers

CRGS's Competitors

Customers & Markets

Economic Indicators

CRGS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071